ID   KSYK_HUMAN              Reviewed;         635 AA.
AC   P43405;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   05-OCT-2010, entry version 131.
DE   RecName: Full=Tyrosine-protein kinase SYK;
DE            EC=2.7.10.2;
DE   AltName: Full=Spleen tyrosine kinase;
GN   Name=SYK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=94220098; PubMed=7513161; DOI=10.1006/bbrc.1994.1409;
RA   Yagi S., Suzuki K., Hasegawa A., Okumura K., Ra C.;
RT   "Cloning of the cDNA for the deleted syk kinase homologous to ZAP-70
RT   from human basophilic leukemia cell line (KU812).";
RL   Biochem. Biophys. Res. Commun. 200:28-34(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=94216354; PubMed=8163536;
RA   Law C.-L., Sidorenko S.P., Chandran K.A., Draves K.E., Chan A.C.,
RA   Weiss A., Edelhoff S., Disteche C.M., Clark E.A.;
RT   "Molecular cloning of human Syk. A B cell protein-tyrosine kinase
RT   associated with the surface immunoglobulin M-B cell receptor
RT   complex.";
RL   J. Biol. Chem. 269:12310-12319(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS LONG AND SHORT).
RC   TISSUE=Eye, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-635.
RC   TISSUE=Tonsil;
RX   MEDLINE=94222446; PubMed=8168854; DOI=10.1007/BF00189234;
RA   Mueller B., Cooper L., Terhorst C.;
RT   "Molecular cloning of the human homologue to the pig protein-tyrosine
RT   kinase syk.";
RL   Immunogenetics 39:359-362(1994).
RN   [5]
RP   INTERACTION WITH EPSTEIN-BARR VIRUS LMP2A.
RX   PubMed=7895172; DOI=10.1016/S1074-7613(95)80040-9;
RA   Miller C.L., Burkhardt A.L., Lee J.H., Stealey B., Longnecker R.,
RA   Bolen J.B., Kieff E.;
RT   "Integral membrane protein 2 of Epstein-Barr virus regulates
RT   reactivation from latency through dominant negative effects on
RT   protein-tyrosine kinases.";
RL   Immunity 2:155-166(1995).
RN   [6]
RP   INTERACTION WITH CBL.
RX   PubMed=9535867; DOI=10.1074/jbc.273.15.8867;
RA   Deckert M., Elly C., Altman A., Liu Y.C.;
RT   "Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn
RT   and Syk tyrosine kinases.";
RL   J. Biol. Chem. 273:8867-8874(1998).
RN   [7]
RP   INTERACTION WITH SLA.
RX   MEDLINE=99380595; PubMed=10449770; DOI=10.1073/pnas.96.17.9775;
RA   Tang J., Sawasdikosol S., Chang J.-H., Burakoff S.J.;
RT   "SLAP, a dimeric adapter protein, plays a functional role in T cell
RT   receptor signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:9775-9780(1999).
RN   [8]
RP   INTERACTION WITH FCRL3.
RX   PubMed=11162587; DOI=10.1006/bbrc.2000.4213;
RA   Xu M.-J., Zhao R., Zhao Z.J.;
RT   "Molecular cloning and characterization of SPAP1, an inhibitory
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 280:768-775(2001).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-348 AND TYR-352, AND
RP   MASS SPECTROMETRY.
RX   MEDLINE=22426906; PubMed=12522270; DOI=10.1073/pnas.2436191100;
RA   Salomon A.R., Ficarro S.B., Brill L.M., Brinker A., Phung Q.T.,
RA   Ericson C., Sauer K., Brock A., Horn D.M., Schultz P.G., Peters E.C.;
RT   "Profiling of tyrosine phosphorylation pathways in human cells using
RT   mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:443-448(2003).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-296; TYR-323; TYR-348;
RP   TYR-352 AND TYR-526, AND MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-323, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-297, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-295; TYR-296; SER-319;
RP   TYR-323 AND TYR-352, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-28, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   INTERACTION WITH SYK, AND FUNCTION.
RX   PubMed=19909739; DOI=10.1016/j.yexcr.2009.10.023;
RA   Cholay M., Reverdy C., Benarous R., Colland F., Daviet L.;
RT   "Functional interaction between the ubiquitin-specific protease 25 and
RT   the SYK tyrosine kinase.";
RL   Exp. Cell Res. 316:667-675(2010).
RN   [17]
RP   STRUCTURE BY NMR OF 163-265.
RX   MEDLINE=96131877; PubMed=8590001; DOI=10.1016/S0969-2126(01)00242-8;
RA   Narula S.S., Yuan R.W., Adams S.E., Green O.M., Green J.,
RA   Philips T.B., Zydowsky L.D., Botfield M.C., Hatada M., Laird E.R.,
RA   Zoller M.J., Karas J.L., Dalgarno D.C.;
RT   "Solution structure of the C-terminal SH2 domain of the human tyrosine
RT   kinase Syk complexed with a phosphotyrosine pentapeptide.";
RL   Structure 3:1061-1073(1995).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 9-262 IN COMPLEX WITH CD3E.
RX   MEDLINE=98365517; PubMed=9698567; DOI=10.1006/jmbi.1998.1964;
RA   Fuetterer K., Wong J., Grucza R.A., Chan A.C., Waksman G.;
RT   "Structural basis for Syk tyrosine kinase ubiquity in signal
RT   transduction pathways revealed by the crystal structure of its
RT   regulatory SH2 domains bound to a dually phosphorylated ITAM
RT   peptide.";
RL   J. Mol. Biol. 281:523-537(1998).
CC   -!- FUNCTION: Positive effector of BCR-stimulated responses. Couples
CC       the B-cell antigen receptor (BCR) to the mobilization of calcium
CC       ion either through a phosphoinositide 3-kinase-dependent pathway,
CC       when not phosphorylated on tyrosines of the linker region, or
CC       through a phospholipase C-gamma-dependent pathway, when
CC       phosphorylated on Tyr-348 and Tyr-352. Thus the differential
CC       phosphorylation of Syk can determine the pathway by which BCR is
CC       coupled to the regulation of intracellular calcium ion (By
CC       similarity). Phosphorylates USP25 and regulates its intracellular
CC       levels.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with RHOH, GAB2 and with NFAM1 (phosphorylated
CC       form). Interacts (via its SH2 domains) with CD79A (via its
CC       phosphorylated ITAM domain); the interaction stimulates SYK
CC       autophosphorylation and activation (By similarity). Interacts
CC       (phosphorylated form) with SLA; the interaction may link it to
CC       CBL, leading to its destruction. Interacts with Epstein-Barr virus
CC       LMP2A. Interacts with FCRL3. Interacts (via the second SH2 domain)
CC       with USP25 (via C-terminus).
CC   -!- INTERACTION:
CC       P20273:CD22; NbExp=1; IntAct=EBI-78302, EBI-78277;
CC       P30273:FCER1G; NbExp=1; IntAct=EBI-78302, EBI-515289;
CC       P05107:ITGB2; NbExp=1; IntAct=EBI-78302, EBI-300173;
CC       O43914:TYROBP; NbExp=1; IntAct=EBI-78302, EBI-2214794;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P43405-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P43405-2; Sequence=VSP_005010;
CC   -!- PTM: Autophosphorylated.
CC   -!- PTM: Phosphorylation on Tyr-323 creates a binding site for c-Cbl,
CC       an adapter protein that serves as a negative regulator of BCR-
CC       stimulated calcium ion signaling (By similarity).
CC   -!- PTM: Phosphorylation on Tyr-348 and Tyr-352 enhances the
CC       phosphorylation and activation of phospholipase C-gamma and the
CC       early phase of calcium ion mobilization via a phosphoinositide 3-
CC       kinase-independent pathway (By similarity).
CC   -!- PTM: Ubiquitinated by CBLB after BCR activation; which promotes
CC       proteasomal degradation (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SYK/ZAP-70 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 2 SH2 domains.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SYKID394.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z29630; CAA82737.1; -; mRNA.
DR   EMBL; L28824; AAA36526.1; -; mRNA.
DR   EMBL; BC001645; AAH01645.1; -; mRNA.
DR   EMBL; BC011399; AAH11399.1; -; mRNA.
DR   EMBL; BC002962; AAH02962.1; -; mRNA.
DR   EMBL; X73568; CAA51970.1; -; mRNA.
DR   IPI; IPI00018597; -.
DR   IPI; IPI00218278; -.
DR   PIR; A53596; A53596.
DR   RefSeq; NP_001128524.1; -.
DR   RefSeq; NP_001167638.1; -.
DR   RefSeq; NP_001167639.1; -.
DR   RefSeq; NP_003168.2; -.
DR   UniGene; Hs.371720; -.
DR   PDB; 1A81; X-ray; 3.00 A; A/C/E/G/I/K=9-262.
DR   PDB; 1CSY; NMR; -; A=163-265.
DR   PDB; 1CSZ; NMR; -; A=163-265.
DR   PDB; 1XBA; X-ray; 2.00 A; A=356-635.
DR   PDB; 1XBB; X-ray; 1.57 A; A=356-635.
DR   PDB; 1XBC; X-ray; 2.00 A; A=356-635.
DR   PDB; 3BUW; X-ray; 1.45 A; A/C=317-329.
DR   PDB; 3EMG; X-ray; 2.60 A; A=349-635.
DR   PDB; 3FQE; X-ray; 2.50 A; A=356-635.
DR   PDB; 3FQH; X-ray; 2.26 A; A/B=356-635.
DR   PDB; 3FQS; X-ray; 2.10 A; A=356-635.
DR   PDBsum; 1A81; -.
DR   PDBsum; 1CSY; -.
DR   PDBsum; 1CSZ; -.
DR   PDBsum; 1XBA; -.
DR   PDBsum; 1XBB; -.
DR   PDBsum; 1XBC; -.
DR   PDBsum; 3BUW; -.
DR   PDBsum; 3EMG; -.
DR   PDBsum; 3FQE; -.
DR   PDBsum; 3FQH; -.
DR   PDBsum; 3FQS; -.
DR   ProteinModelPortal; P43405; -.
DR   SMR; P43405; 163-631.
DR   DIP; DIP-253N; -.
DR   IntAct; P43405; 15.
DR   MINT; MINT-148486; -.
DR   STRING; P43405; -.
DR   PhosphoSite; P43405; -.
DR   PeptideAtlas; P43405; -.
DR   PRIDE; P43405; -.
DR   Ensembl; ENST00000375746; ENSP00000364898; ENSG00000165025.
DR   Ensembl; ENST00000375754; ENSP00000364907; ENSG00000165025.
DR   GeneID; 6850; -.
DR   KEGG; hsa:6850; -.
DR   UCSC; uc004aqz.1; human.
DR   CTD; 6850; -.
DR   GeneCards; GC09P093564; -.
DR   H-InvDB; HIX0008158; -.
DR   HGNC; HGNC:11491; SYK.
DR   HPA; CAB007773; -.
DR   HPA; HPA001384; -.
DR   MIM; 600085; gene.
DR   PharmGKB; PA36273; -.
DR   eggNOG; prNOG06189; -.
DR   HOGENOM; HBG714705; -.
DR   HOVERGEN; HBG001540; -.
DR   InParanoid; P43405; -.
DR   OMA; HYSYKAD; -.
DR   OrthoDB; EOG908QT6; -.
DR   PhylomeDB; P43405; -.
DR   BRENDA; 2.7.10.2; 247.
DR   Pathway_Interaction_DB; alphasynuclein_pathway; Alpha-synuclein signaling.
DR   Pathway_Interaction_DB; nfkappabatypicalpathway; Atypical NF-kappaB pathway.
DR   Pathway_Interaction_DB; bcr_5pathway; BCR signaling pathway.
DR   Pathway_Interaction_DB; pi3kcipathway; Class I PI3K signaling events.
DR   Pathway_Interaction_DB; fcer1pathway; Fc-epsilon receptor I signaling in mast cells.
DR   Pathway_Interaction_DB; il2_1pathway; IL2-mediated signaling events.
DR   Pathway_Interaction_DB; avb3_opn_pathway; Osteopontin-mediated events.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Reactome; REACT_604; Hemostasis.
DR   BindingDB; P43405; -.
DR   NextBio; 26739; -.
DR   ArrayExpress; P43405; -.
DR   Bgee; P43405; -.
DR   CleanEx; HS_SYK; -.
DR   Genevestigator; P43405; -.
DR   GermOnline; ENSG00000165025; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0042101; C:T cell receptor complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005178; F:integrin binding; IPI:UniProtKB.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; IEA:EC.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IDA:UniProtKB.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB.
DR   GO; GO:0009887; P:organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0006461; P:protein complex assembly; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR020757; Tyr_kinase_non-rcpt_SYK.
DR   InterPro; IPR012234; Tyr_kinase_non-rcpt_SYK/ZAP70.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   Gene3D; G3DSA:3.30.505.10; SH2; 2.
DR   PANTHER; PTHR23256:SF99; Tyr_kinase_non-rcpt_SYK; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 2.
DR   PIRSF; PIRSF000604; TyrPK_SYK; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 2.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Host-virus interaction; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Repeat; SH2 domain; Transferase;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   CHAIN         1    635       Tyrosine-protein kinase SYK.
FT                                /FTId=PRO_0000088165.
FT   DOMAIN       15    107       SH2 1.
FT   DOMAIN      168    259       SH2 2.
FT   DOMAIN      371    631       Protein kinase.
FT   NP_BIND     377    385       ATP (By similarity).
FT   REGION      260    370       Linker.
FT   ACT_SITE    494    494       Proton acceptor (By similarity).
FT   BINDING     402    402       ATP (By similarity).
FT   MOD_RES      28     28       Phosphotyrosine.
FT   MOD_RES     295    295       Phosphoserine.
FT   MOD_RES     296    296       Phosphotyrosine.
FT   MOD_RES     297    297       Phosphoserine.
FT   MOD_RES     316    316       Phosphoserine (By similarity).
FT   MOD_RES     319    319       Phosphoserine.
FT   MOD_RES     323    323       Phosphotyrosine; by LYN.
FT   MOD_RES     348    348       Phosphotyrosine.
FT   MOD_RES     352    352       Phosphotyrosine.
FT   MOD_RES     525    525       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     526    526       Phosphotyrosine.
FT   MOD_RES     546    546       Phosphotyrosine (By similarity).
FT   MOD_RES     629    629       Phosphotyrosine (By similarity).
FT   MOD_RES     630    630       Phosphotyrosine (By similarity).
FT   VAR_SEQ     283    305       Missing (in isoform Short).
FT                                /FTId=VSP_005010.
FT   VARIANT      45     45       R -> H (in dbSNP:rs16906862).
FT                                /FTId=VAR_033838.
FT   CONFLICT    119    119       P -> A (in Ref. 4; CAA51970).
FT   CONFLICT    250    250       G -> P (in Ref. 4; CAA51970).
FT   STRAND      166    169
FT   HELIX       176    184
FT   STRAND      191    195
FT   STRAND      198    201
FT   STRAND      203    211
FT   STRAND      213    219
FT   STRAND      222    224
FT   STRAND      229    231
FT   HELIX       237    244
FT   STRAND      251    253
FT   HELIX       367    369
FT   STRAND      370    379
FT   STRAND      384    391
FT   STRAND      396    403
FT   HELIX       412    424
FT   STRAND      435    449
FT   HELIX       456    462
FT   HELIX       468    487
FT   HELIX       497    499
FT   STRAND      500    504
FT   STRAND      507    510
FT   STRAND      524    527
FT   HELIX       536    538
FT   HELIX       541    546
FT   STRAND      548    550
FT   HELIX       551    566
FT   TURN        567    569
FT   HELIX       578    586
FT   HELIX       599    608
FT   HELIX       613    615
FT   HELIX       619    635
SQ   SEQUENCE   635 AA;  72066 MW;  EAA6BDE65881FC68 CRC64;
     MASSGMADSA NHLPFFFGNI TREEAEDYLV QGGMSDGLYL LRQSRNYLGG FALSVAHGRK
     AHHYTIEREL NGTYAIAGGR THASPADLCH YHSQESDGLV CLLKKPFNRP QGVQPKTGPF
     EDLKENLIRE YVKQTWNLQG QALEQAIISQ KPQLEKLIAT TAHEKMPWFH GKISREESEQ
     IVLIGSKTNG KFLIRARDNN GSYALCLLHE GKVLHYRIDK DKTGKLSIPE GKKFDTLWQL
     VEHYSYKADG LLRVLTVPCQ KIGTQGNVNF GGRPQLPGSH PATWSAGGII SRIKSYSFPK
     PGHRKSSPAQ GNRQESTVSF NPYEPELAPW AADKGPQREA LPMDTEVYES PYADPEEIRP
     KEVYLDRKLL TLEDKELGSG NFGTVKKGYY QMKKVVKTVA VKILKNEAND PALKDELLAE
     ANVMQQLDNP YIVRMIGICE AESWMLVMEM AELGPLNKYL QQNRHVKDKN IIELVHQVSM
     GMKYLEESNF VHRDLAARNV LLVTQHYAKI SDFGLSKALR ADENYYKAQT HGKWPVKWYA
     PECINYYKFS SKSDVWSFGV LMWEAFSYGQ KPYRGMKGSE VTAMLEKGER MGCPAGCPRE
     MYDLMNLCWT YDVENRPGFA AVELRLRNYY YDVVN
//
